Analytical method development and validation of Secnidazole in the tablet dosage form by RP-HPLC method
DOI:
https://doi.org/10.3329/icpj.v5i4.27020Keywords:
Secnidazole, HPLC, Nitroimidazole, pharmaceutical, Shimadzu, validationAbstract
Objective of the present work is to develop and validate a simple, cost effective, sensitive and fast HPLC method for the analysis of Secnidazole. A Shimadzu HPLC system with Luna 5µm C18 column is employed for the analysis using Methanol:H2O (60:40, v/v) as mobile phase. Signal from Secnidazole is detected at 310nm by UV Spectrophotometer. The proposed method is fully validated and found to be linear over a workable drug concentration, accurate, precise and robust. This fast and inexpensive method is suitable for research laboratories as well as for quality control analysis in pharmaceutical industries.
Sharmin et al., International Current Pharmaceutical Journal, March 2016, 5(4): 41-44
Downloads
153
97
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- The journal holds copyright and publishes the work under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).